Swiss Re AG 2025 Q3 – Results – Earnings Call Presentation

A Canadian stock earns “trust for the next 10 years” when it keeps winning in three different markets: good times, bad times, and boring times. It needs a durable advantage, recurring revenue, and leadership that treats capital like it is precious. I also want a business that can grow without constantly issuing shares or taking…

The Strait of Hormuz is just 33 kilometres wide at its narrowest point. Right now, it’s the most dangerous stretch of water on the planet. Since US and Israeli strikes on Iran last Saturday, the Strait has shifted from the world’s busiest energy highway to a no-go zone. Around 200 tankers are now stranded. At…

Kalshi is shaking up finance with its novel approach to trading event contracts — financial instruments that let users take positions on the outcomes of real-world events. It’s a new way to engage with global developments, bridging traditional markets and prediction systems. But unlike many prediction platforms, Kalshi operates under U.S. federal oversight, adding a…

Building a diversified portfolio that can provide monthly dividend payments requires picking the right investments, having capital to invest, and some patience. Fortunately, if investors do look to add one or more of those monthly dividend stocks, there are more than a few great candidates to choose from, but first, let’s talk about the Tax-Free…

Novartis AG (NYSE:NVS) J.P. Morgan 43rd Annual Healthcare Conference January 14, 2025 12:00 PM ET Company Participants Vas Narasimhan – Chief Executive Officer Conference Call Participants Richard Vosser – J.P. Morgan Richard Vosser Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I’m Richard Vosser, European pharma analyst with JPMorgan. It’s my great…